Cite
HARVARD Citation
Shien, T. et al. (n.d.). 134P Safety and efficacy of eribulin and trastuzumab in anti-HER2 therapy pretreated patients with HER2-positive metastatic breast cancer: A Japanese multicenter phase 2 study (SBP-04 study). Annals of oncology. p. . [Online].